Cyclophilins and gibberellin-regulated proteins in IgE-mediated allergic diseases

Q3 Medicine

Allergo Journal International Pub Date : 2023-10-04 DOI:10.1007/s40629-023-00270-9

Ekaterina Potapova, Hélène Sénéchal PhD, Enrico Scala, Paolo Maria Matricardi, Pascal Poncet PhD

{"title":"Cyclophilins and gibberellin-regulated proteins in IgE-mediated allergic diseases","authors":"Ekaterina Potapova,  Hélène Sénéchal PhD,  Enrico Scala,  Paolo Maria Matricardi,  Pascal Poncet PhD","doi":"10.1007/s40629-023-00270-9","DOIUrl":null,"url":null,"abstract":"<div><h2>Summary</h2><div><p>The prevalence of immunoglobulin E (IgE)-mediated allergic diseases is currently experiencing an epidemic trend characterized by an increase in both the number of affected individuals and the proportion of patients with multiple sensitizations. The majority of these multiple sensitizations are attributed to IgE reactions to genuine allergenic proteins from unrelated species. However, there is a growing trend of patients becoming sensitized to highly cross-reactive molecules, such as profilins, polcalcins, lipocalins, serum albumins, tropomyosins, and non-specific lipid transfer proteins (nsLTPs). In addition, allergen families that were previously considered of minimal importance are now gaining recognition for their role in the pathogenesis of IgE-mediated allergic diseases. Consequently, these allergen families are increasingly being considered in the diagnostic process. In this review, we aim to provide a comprehensive summary of the biochemical and allergological information about two of these “new” allergen families: cyclophilins (Cyp) and gibberellin-regulated proteins (GRP).</p></div></div>","PeriodicalId":37457,"journal":{"name":"Allergo Journal International","volume":"32 7","pages":"280 - 288"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s40629-023-00270-9.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Allergo Journal International","FirstCategoryId":"1085","ListUrlMain":"https://link.springer.com/article/10.1007/s40629-023-00270-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Summary

The prevalence of immunoglobulin E (IgE)-mediated allergic diseases is currently experiencing an epidemic trend characterized by an increase in both the number of affected individuals and the proportion of patients with multiple sensitizations. The majority of these multiple sensitizations are attributed to IgE reactions to genuine allergenic proteins from unrelated species. However, there is a growing trend of patients becoming sensitized to highly cross-reactive molecules, such as profilins, polcalcins, lipocalins, serum albumins, tropomyosins, and non-specific lipid transfer proteins (nsLTPs). In addition, allergen families that were previously considered of minimal importance are now gaining recognition for their role in the pathogenesis of IgE-mediated allergic diseases. Consequently, these allergen families are increasingly being considered in the diagnostic process. In this review, we aim to provide a comprehensive summary of the biochemical and allergological information about two of these “new” allergen families: cyclophilins (Cyp) and gibberellin-regulated proteins (GRP).

查看原文本刊更多论文

IgE介导的过敏性疾病中的亲环素和赤霉素调节蛋白

综述免疫球蛋白E（IgE）介导的过敏性疾病的患病率目前正经历一种流行趋势，其特征是受影响的个体数量和多重致敏患者比例都在增加。这些多重致敏大多归因于IgE对来自无关物种的真正致敏蛋白的反应。然而，患者对高度交叉反应分子（如轮廓蛋白、polcalcins、脂质运载蛋白、血清白蛋白、原肌球蛋白和非特异性脂质转移蛋白（nsLTP））越来越敏感。此外，以前被认为最不重要的过敏原家族现在因其在IgE介导的过敏性疾病发病机制中的作用而获得认可。因此，在诊断过程中越来越多地考虑这些过敏原家族。在这篇综述中，我们的目的是提供关于这两个“新”过敏原家族的生化和变态反应学信息的全面总结：亲环蛋白（Cyp）和赤霉素调节蛋白（GRP）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Allergo Journal International Medicine-Immunology and Allergy

CiteScore

4.60

自引率

0.00%

发文量

期刊介绍： Allergo Journal International is the official Journal of the German Society for Applied Allergology (AeDA) and the Austrian Society for Allergology and Immunology (ÖGAI). The journal is a forum for the communication and exchange of ideas concerning the various aspects of allergy (including related fields such as clinical immunology and environmental medicine) and promotes German allergy research in an international context. The aim of Allergo Journal International is to provide state of the art information for all medical and scientific disciplines that deal with allergic, immunological and environmental diseases. Allergo Journal International publishes original articles, reviews, short communications, case reports, and letters to the editor. The articles cover topics such as allergic, immunological and environmental diseases, the latest developments in diagnosis and therapy as well as current research work concerning antigens and allergens and aspects related to occupational and environmental medicine. In addition, it publishes clinical guidelines and position papers approved by expert panels of the German, Austrian and Swiss Allergy Societies. All submissions are reviewed in single-blind fashion by at least two reviewers. Originally, the journal started as a German journal called Allergo Journal back in 1992. Throughout the years, English articles amounted to a considerable portion in Allergo Journal. This was one of the reasons to extract the scientific content and publish it in a separate journal. Hence, Allergo Journal International was born and now is the international continuation of the original German journal. Nowadays, all original content is published in Allergo Journal International first. Later, selected manuscripts will be translated and published in German and included in Allergo Journal.